Finch Therapeutics Receives Green Light for Creditor Voting on Chapter 11 Plan, Signaling Key Restructuring Progress
Finch Therapeutics, a developer specializing in microbiome treatments, received conditional approval from a Delaware bankruptcy judge to proceed with soliciting creditor votes on its Chapter 11 plan. This decision marks a significant step forward in the company’s restructuring efforts under bankruptcy protection. The conditional approval of the disclosure statement, as reported by Law360, enables Finch…